Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity

Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more than 80 % of neonates with a birth weight less than 1,000 g. Methylxanthine therapies, including caffeine and theophylline, are a mainstay in the treatment and prevention of AOP. Despite their frequent use, litt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Paediatr Drugs
Hauptverfasser: Schoen, Katherine, Yu, Tian, Stockmann, Chris, Spigarelli, Michael G., Sherwin, Catherine M. T.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609880/
https://ncbi.nlm.nih.gov/pubmed/24399614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-013-0063-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge